Highlighting Moffitt Cancer Center’s Breakthrough Research

Inspiring science, fueling progress and revolutionizing care is the focus of this year’s American Association for Cancer Research annual meeting. The global cancer research community — including scientists, clinicians, health care professionals, patients and advocates — is gathering April 5-10 in San Diego to share the latest developments. Meeting organizers report record-breaking attendance and a record number of abstracts submitted.

#AACR24 in one word: WOW! I was honored to speak at today’s Opening Ceremony. You could feel the energy from the audience—an exciting start to what promises to be a fabulous meeting! pic.twitter.com/PoU0Z3buui
— Dr. Kimryn Rathmell (@NCIDirector) April 7, 2024

The meeting kicked off with an inspiring address from National Cancer Institute Director Kimryn Rathmell, MD, PhD. She recalled her time attending the meeting as a postdoctoral fellow and wanted young investigators to know that they are the future of cancer research. “There is a future NCI director in you,” she said. Rathmell also highlighted the biggest discoveries of the year. “I want to mention the effective partnerships with Moffitt Cancer Center and Iovance on the clinical trial that was critical to FDA approval of lifileucel.”

Moffitt Cancer Center faculty, postdocs and students will be presenting innovative science over the next several days. This includes nine major and minor symposia, two education sessions, two late breaking abstracts and 34 posters.

Read more about these cancer research discoveries below.